Markers Linked to Angiogenesis in Breast Cancer
Author Information
Author(s): Götte Martin, Kersting Christian, Radke Isabel, Kiesel Ludwig, Wülfing Pia
Primary Institution: Münster University Hospital
Hypothesis
Does coexpression of syndecan-1, E-cadherin, and c-met constitute a prognostic expression signature in ductal carcinoma in situ (DCIS) of the breast?
Conclusion
Syndecan-1, E-cadherin, and c-met form a marker signature associated with angiogenic and lymphangiogenic factors in DCIS, which may influence tumor progression.
Supporting Evidence
- Coexpression of syndecan-1, E-cadherin, and c-met was confirmed in breast cancer cell lines.
- 72% of DCIS samples showed strong positive staining for syndecan-1.
- E-cadherin expression was significantly associated with c-met and syndecan-1.
- c-met and syndecan-1 expression was more frequent in pure DCIS than in DCIS with invasive carcinoma.
- c-met expression correlated with angiogenic factors like VEGF-A.
Takeaway
This study found that certain markers in breast cancer can work together to help the cancer grow and spread, which could help doctors find better treatments.
Methodology
The study used immunohistochemistry on a tissue microarray of tumor specimens from 200 DCIS patients to evaluate the expression of syndecan-1, E-cadherin, and c-met.
Potential Biases
Potential biases may arise from the selection of patients and the interpretation of immunohistochemical staining.
Limitations
The study's findings may not be generalizable due to the specific patient population and the focus on early-stage breast cancer.
Participant Demographics
Median age of patients was 59 years, with a range from 18 to 94 years.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website